Abstract:The outcome of bacterial infection management relies on prompt diagnosis and effective treatment, but conventional antimicrobial susceptibility testing can be slow and labor-intensive. Therefore, this study aims to predict phenotypic antimicrobial susceptibility of selected beta-lactam antimicrobials in the bacteria of the family Enterobacteriaceae from different beta-lactamase resistance genotypes. Using human datasets extracted from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program conducted by Pfizer and retail meat datasets from the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), we used a robust or weighted least square multivariable linear regression modeling framework to explore the relationship between antimicrobial susceptibility data of beta-lactam antimicrobials and different types of beta-lactamase resistance genes. In humans, in the presence of the blaCTX-M-1, blaCTX-M-2, blaCTX-M-8/25, and blaCTX-M-9 groups, MICs of cephalosporins significantly increased by values between 0.34–3.07 μg/mL, however, the MICs of carbapenem significantly decreased by values between 0.81–0.87 μg/mL. In the presence of carbapenemase genes (blaKPC, blaNDM, blaIMP, and blaVIM), the MICs of cephalosporin antimicrobials significantly increased by values between 1.06–5.77 μg/mL, while the MICs of carbapenem antimicrobials significantly increased by values between 5.39–67.38 μg/mL. In retail meat, MIC of ceftriaxone increased significantly in the presence of blaCMY-2, blaCTX-M-1, blaCTX-M-55, blaCTX-M-65, and blaSHV-2 by 55.16 μg/mL, 222.70 μg/mL, 250.81 μg/mL, 204.89 μg/mL, and 31.51 μg/mL respectively. MIC of cefoxitin increased significantly in the presence of blaCTX-M-65 and blaTEM-1 by 1.57 μg/mL and 1.04 μg/mL respectively. In the presence of blaCMY-2, MIC of cefoxitin increased by an average of 8.66 μg/mL over 17 years. Compared to E. coli isolates, MIC of cefoxitin in Salmonella enterica isolates decreased significantly by 0.67 μg/mL. On the other hand, MIC of ceftiofur increased in the presence of blaCTX-M-1, blaCTX-M-65, blaSHV-2, and blaTEM-1 by 8.82 μg/mL, 9.11 μg/mL, 8.18 μg/mL, and 1.04 μg/mL respectively. In the presence of blaCMY-2, MIC of ceftiofur increased by an average of 10.20 μg/mL over 14 years. The ability to predict antimicrobial susceptibility of beta-lactam antimicrobials directly from beta-lactamase resistance genes may help reduce the reliance on routine phenotypic testing with higher turnaround times in diagnostic, therapeutic, and surveillance of antimicrobial-resistant bacteria of the family Enterobacteriaceae.

Machine Learning and Deep Learning Models for Predicting Noncovalent Inhibitors of AmpC β-Lactamase

Predicting Antimicrobial Activity of Conjugated Oligoelectrolyte Molecules via Machine Learning

Deciphering the co-evolutionary dynamics of L2 β-lactamases via Deep learning

Identification of key drivers of antimicrobial resistance in Enterococcus using machine learning

Applications of machine-learning methods for the discovery of NDM-1 inhibitors

Prediction of Linear Cationic Antimicrobial Peptides Active against Gram Negative and Positive Bacteria Based on Machine Learning Models

An ensemble deep learning model for predicting minimum inhibitory concentrations of antimicrobial peptides against pathogenic bacteria

Prediction of Antibiotic Susceptibility in E. coli Isolates Using Machine Learning

Improved prediction of antimicrobial resistance in using machine learning

CalcAMP: A New Machine Learning Model for the Accurate Prediction of Antimicrobial Activity of Peptides

ABDpred: Prediction of active antimicrobial compounds using supervised machine learning techniques

Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning

Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance

A Pragmatic Machine Learning Model To Predict Carbapenem Resistance

Prediction of antibiotic resistant strains of bacteria from their beta-lactamases protein

AmpClass: an Antimicrobial Peptide Predictor Based on Supervised Machine Learning

Prediction of antibiotic resistance in Escherichia coli from large-scale pan-genome data

Predictive Modeling of Phenotypic Antimicrobial Susceptibility of Selected Beta-Lactam Antimicrobials from Beta-Lactamase Resistance Genes

Prediction of ciprofloxacin resistance in hospitalized patients using machine learning

Predicting antimicrobial class specificity of small molecules using machine learning

Integrative Machine Learning, Virtual Screening, and Molecular Modeling for BacA-Targeted Anti-Biofilm Drug Discovery Against Staphylococcal Infections